Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-trimester multi-modal cell-free DNA analysis for prediction of preterm and term preeclampsia.

AJOG global reports·2026
Same author

Multi-Omics Reveals Early Pregnancy Placental Dysfunction Associated With Preterm and Term Preeclampsia.

MedComm·2026
Same author

Pre-eclampsia risk-stratified planned birth at term: A survey of women's perspectives on acceptability and risk communication.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Healthcare professionals' perceptions of the acceptability of the PREVENT-PE trial: A mixed-methods survey and interview study.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Scheduled birth at term: benefit or trade-off? - Authors' reply.

Lancet (London, England)·2026
Same author

In women with chronic hypertension, does fetal growth restriction increase progression to maternal preeclampsia?

American journal of obstetrics and gynecology·2026

Related Experiment Video

Updated: May 20, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A competing risks model in early screening for preeclampsia.

David Wright1, Ranjit Akolekar, Argyro Syngelaki

  • 1School of Computing and Mathematics, Plymouth University, Plymouth, UK.

Fetal Diagnosis and Therapy
|August 1, 2012
PubMed
Summary
This summary is machine-generated.

A new model effectively screens for preeclampsia (PE) in the first trimester using maternal factors and biophysical markers. This approach improves early detection rates for PE, aiding timely intervention.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Related Experiment Videos

Last Updated: May 20, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Preeclampsia (PE) is a significant complication of pregnancy.
  • Early detection of PE is crucial for improving maternal and fetal outcomes.
  • First-trimester screening for PE can enable timely interventions.

Purpose of the Study:

  • To develop predictive models for preeclampsia (PE) using first-trimester maternal characteristics and biophysical markers.
  • To treat gestational age at delivery for PE as a continuous variable in model development.
  • To enhance the accuracy of early PE detection.

Main Methods:

  • A screening study involving singleton pregnancies at 11-13 weeks' gestation.
  • Development of a survival time model incorporating maternal characteristics, uterine artery pulsatility index (PI), and mean arterial pressure (MAP).
  • Utilized Bayes' theorem to combine prior information with biophysical markers.

Main Results:

  • Identified risk factors for PE including maternal age, weight, ethnicity, previous PE, IVF conception, and medical history (hypertension, diabetes, autoimmune conditions).
  • Observed an inverse correlation between uterine artery PI and MAP multiples of the median with gestational age at delivery in PE pregnancies.
  • Screening model detected 90% of PE cases requiring delivery before 34 weeks and 57% of all PE cases at a 10% false-positive rate.

Conclusions:

  • A novel and effective first-trimester screening model for preeclampsia has been developed.
  • The model integrates maternal characteristics with biophysical markers for improved prediction.
  • This advancement supports earlier identification and management of PE.